Page last updated: 2024-11-03

risperidone and Insulinoma

risperidone has been researched along with Insulinoma in 1 studies

Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.

Insulinoma: A benign tumor of the PANCREATIC BETA CELLS. Insulinoma secretes excess INSULIN resulting in HYPOGLYCEMIA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Ninagawa, S1
Tada, S1
Okumura, M1
Inoguchi, K1
Kinoshita, M1
Kanemura, S1
Imami, K1
Umezawa, H1
Ishikawa, T1
Mackin, RB1
Torii, S1
Ishihama, Y1
Inaba, K1
Anazawa, T1
Nagamine, T1
Mori, K1

Other Studies

1 other study available for risperidone and Insulinoma

ArticleYear
Antipsychotic olanzapine-induced misfolding of proinsulin in the endoplasmic reticulum accounts for atypical development of diabetes.
    eLife, 2020, 11-17, Volume: 9

    Topics: Animals; Antipsychotic Agents; Cell Line, Tumor; Diabetes Mellitus; Endoplasmic Reticulum; Insulinom

2020